The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $25.66

Today's change-0.40 -1.53%
Updated September 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $25.66

Today's change-0.40 -1.53%
Updated September 21 4:00 PM EDT. Delayed by at least 15 minutes.

Wright Medical Group NV down (U.S.)$0.40

Wright Medical Group NV closed sharply lower Thursday, dropping (U.S.)$0.40 or 1.53% to (U.S.)$25.66. Shares have lost 6.49% over the last five days, but have gained 11.66% over the last year to date. This security has underperformed the S&P 500 by 7.65% during the last year.

Key company metrics

  • Open(U.S.) $26.01
  • Previous close(U.S.) $26.06
  • High(U.S.) $26.01
  • Low(U.S.) $25.57
  • Bid / Ask-- / --
  • YTD % change+11.66%
  • Volume742,201
  • Average volume (10-day)1,091,407
  • Average volume (1-month)917,891
  • Average volume (3-month)1,008,815
  • 52-week range(U.S.) $20.50 to (U.S.) $31.53
  • Beta0.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.36
Updated September 21 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-19.85%

Wright Medical Group NV has a net profit margin of -19.85%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.42%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 25, 201706/25/2017Mar 26, 201703/26/2017Dec 25, 201612/25/2016Sep 25, 201609/25/2016
Revenue180177193157
Total other revenue--------
Total revenue180177193157
Gross profit142140142111
Total cost of revenue38375146
Total operating expense188187212196
Selling / general / administrative131130140130
Research & development13121412
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-9-10-19-39
Interest income (expense), net non-operating-18-18-17-17
Gain (loss) on sale of assets--------
Other--------
Income before tax-21-36-36-55
Income after tax-21-37-30-53
Income tax, total01-6-2
Net income-41-59-45-110
Total adjustments to net income--------
Net income before extra. items-21-37-30-53
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-21-37-30-53
Inc. avail. to common incl. extra. items-41-59-45-110
Diluted net income-41-59-45-110
Dilution adjustment------0
Diluted weighted average shares104104103103
Diluted EPS excluding extraordinary itemsvalue per share-0.20-0.35-0.29-0.51
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.20-0.35-0.29-0.51